Answers are grounded in this paper and cite their sources.
Background Endometriosis is an implantation and growth of endometrial-like tissue (glands and stroma) outside the uterine cavity, while adenomyosis is a growth the tissue in the myometrium. This pathology affects every tenth women in the world, but the treatment is not effective due to unclear initial mechanisms of this disease. Methods Using primary cells from patients with endometriosis and adenomyosis we studied the role of mitochondrial energy metabolism and redox balance in the cellular mechanism of pathology. Results We have found that cells with endometriosis or adenomyosis induced reactive oxygen species (ROS) overproduction from NADPH oxidase that trigger lipid peroxidation and decreased the level of glutathione. Patients’ cells were characterized by abnormal mitochondrial membrane potential and redox index due to the lack of mitochondrial NADH. Mitochondrial dysfunction led to increased rate of ROS production in this organelle. Inhibitors of NADPH oxidase or PARP restored mitochondrial NADH level and mitochondrial membrane potential suggesting that production of ROS in NADPH oxidase activates PARP that sequestering NADH in mitochondria and leads to mitochondrial dysfunction. Importantly, patients’ cells with recurrence of pathology exhibit the same pathology despite the intensive hormone treatment. Conclusions Thus, activation of NADPH oxidase trigger overactivation of PARP that lead to mitochondrial dysfunction could be the initial mechanism of pathogenesis of endometriosis and adenomyosis. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Vinokurov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: